Meaningful patient representation informing Canada%26apos;s cancer drug funding decisions: views of patient representatives on the Pan-Canadian Oncology Drug Review

作者：Hoch J S^*; Brown M B; McMahon C; Nanson J; Rozmovits L

来源：Current Oncology, 2014, 21(5): 263-266.

DOI：10.3747/co.21.2128

• Oncology drug funding
• pCODR
• health economics

In this interview with the patient representatives on the Expert Review Committee (PERC) of the Pan-Canadian Oncology Drug Review (PCODR), those representatives offer their views about how to be a valuable contributing member of Canada%26apos;s national cancer drug funding recommendation committee. The article seeks to inform readers, and especially clinicians, about PCODR from the perspective of the patient representatives.

• 出版日期2014-10
• 单位Saskatchewan; Saskatoon